 | • レポートコード：MRC308GR11412 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のジペプチジルペプチダーゼ-4阻害剤の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のジペプチジルペプチダーゼ-4阻害剤市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– ジペプチジルペプチダーゼ-4阻害剤の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
ジペプチジルペプチダーゼ-4阻害剤市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・シタグリプチン、サクサグリプチン、ビルダグリプチン、リナグリプチン、アログリプチン、その他
用途別セグメント
・病院、診療所、その他
主要な市場プレーヤー
・Merck、Boehringer Ingelheim、AstraZeneca、Takeda Pharmaceutical、Novartis、Jiangsu Hansoh Pharmaceutical、Qilu Pharmaceutical、Beijing Tide Pharmaceutical、CTTQ、Jiangsu Deyuan Pharmaceutical、Jiujiang Zhongtian Pharmaceutical、Yabao Pharmaceutical
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、ジペプチジルペプチダーゼ-4阻害剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なジペプチジルペプチダーゼ-4阻害剤メーカーの企業概要、2019年～2022年までのジペプチジルペプチダーゼ-4阻害剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なジペプチジルペプチダーゼ-4阻害剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別ジペプチジルペプチダーゼ-4阻害剤の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのジペプチジルペプチダーゼ-4阻害剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのジペプチジルペプチダーゼ-4阻害剤市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびジペプチジルペプチダーゼ-4阻害剤の産業チェーンを掲載しています。
・第14、15章では、ジペプチジルペプチダーゼ-4阻害剤の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– ジペプチジルペプチダーゼ-4阻害剤の概要
– 種類別分析（2018年vs2022年vs2029年）：シタグリプチン、サクサグリプチン、ビルダグリプチン、リナグリプチン、アログリプチン、その他
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所、その他
– 世界のジペプチジルペプチダーゼ-4阻害剤市場規模・予測
– 世界のジペプチジルペプチダーゼ-4阻害剤生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Merck、Boehringer Ingelheim、AstraZeneca、Takeda Pharmaceutical、Novartis、Jiangsu Hansoh Pharmaceutical、Qilu Pharmaceutical、Beijing Tide Pharmaceutical、CTTQ、Jiangsu Deyuan Pharmaceutical、Jiujiang Zhongtian Pharmaceutical、Yabao Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：シタグリプチン、サクサグリプチン、ビルダグリプチン、リナグリプチン、アログリプチン、その他
・用途別分析2018年-2029年：病院、診療所、その他
・ジペプチジルペプチダーゼ-4阻害剤の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ジペプチジルペプチダーゼ-4阻害剤のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ジペプチジルペプチダーゼ-4阻害剤のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ジペプチジルペプチダーゼ-4阻害剤の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ジペプチジルペプチダーゼ-4阻害剤の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Dipeptidyl Peptidase-4 Inhibitors
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Sitagliptin
1.3.3 Saxagliptin
1.3.4 Vildagliptin
1.3.5 Linagliptin
1.3.6 Alogliptin
1.3.7 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Dipeptidyl Peptidase-4 Inhibitors Market Size & Forecast
1.5.1 Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Dipeptidyl Peptidase-4 Inhibitors Sales Quantity (2018-2029)
1.5.3 Global Dipeptidyl Peptidase-4 Inhibitors Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Dipeptidyl Peptidase-4 Inhibitors Product and Services
2.1.4 Merck Dipeptidyl Peptidase-4 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Dipeptidyl Peptidase-4 Inhibitors Product and Services
2.2.4 Boehringer Ingelheim Dipeptidyl Peptidase-4 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boehringer Ingelheim Recent Developments/Updates
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Dipeptidyl Peptidase-4 Inhibitors Product and Services
2.3.4 AstraZeneca Dipeptidyl Peptidase-4 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 AstraZeneca Recent Developments/Updates
2.4 Takeda Pharmaceutical
2.4.1 Takeda Pharmaceutical Details
2.4.2 Takeda Pharmaceutical Major Business
2.4.3 Takeda Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product and Services
2.4.4 Takeda Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Takeda Pharmaceutical Recent Developments/Updates
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Dipeptidyl Peptidase-4 Inhibitors Product and Services
2.5.4 Novartis Dipeptidyl Peptidase-4 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Novartis Recent Developments/Updates
2.6 Jiangsu Hansoh Pharmaceutical
2.6.1 Jiangsu Hansoh Pharmaceutical Details
2.6.2 Jiangsu Hansoh Pharmaceutical Major Business
2.6.3 Jiangsu Hansoh Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product and Services
2.6.4 Jiangsu Hansoh Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
2.7 Qilu Pharmaceutical
2.7.1 Qilu Pharmaceutical Details
2.7.2 Qilu Pharmaceutical Major Business
2.7.3 Qilu Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product and Services
2.7.4 Qilu Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Qilu Pharmaceutical Recent Developments/Updates
2.8 Beijing Tide Pharmaceutical
2.8.1 Beijing Tide Pharmaceutical Details
2.8.2 Beijing Tide Pharmaceutical Major Business
2.8.3 Beijing Tide Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product and Services
2.8.4 Beijing Tide Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Beijing Tide Pharmaceutical Recent Developments/Updates
2.9 CTTQ
2.9.1 CTTQ Details
2.9.2 CTTQ Major Business
2.9.3 CTTQ Dipeptidyl Peptidase-4 Inhibitors Product and Services
2.9.4 CTTQ Dipeptidyl Peptidase-4 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 CTTQ Recent Developments/Updates
2.10 Jiangsu Deyuan Pharmaceutical
2.10.1 Jiangsu Deyuan Pharmaceutical Details
2.10.2 Jiangsu Deyuan Pharmaceutical Major Business
2.10.3 Jiangsu Deyuan Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product and Services
2.10.4 Jiangsu Deyuan Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
2.11 Jiujiang Zhongtian Pharmaceutical
2.11.1 Jiujiang Zhongtian Pharmaceutical Details
2.11.2 Jiujiang Zhongtian Pharmaceutical Major Business
2.11.3 Jiujiang Zhongtian Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product and Services
2.11.4 Jiujiang Zhongtian Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Jiujiang Zhongtian Pharmaceutical Recent Developments/Updates
2.12 Yabao Pharmaceutical
2.12.1 Yabao Pharmaceutical Details
2.12.2 Yabao Pharmaceutical Major Business
2.12.3 Yabao Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product and Services
2.12.4 Yabao Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Yabao Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Dipeptidyl Peptidase-4 Inhibitors by Manufacturer
3.1 Global Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Manufacturer (2018-2023)
3.2 Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Manufacturer (2018-2023)
3.3 Global Dipeptidyl Peptidase-4 Inhibitors Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Dipeptidyl Peptidase-4 Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Dipeptidyl Peptidase-4 Inhibitors Manufacturer Market Share in 2022
3.4.2 Top 6 Dipeptidyl Peptidase-4 Inhibitors Manufacturer Market Share in 2022
3.5 Dipeptidyl Peptidase-4 Inhibitors Market: Overall Company Footprint Analysis
3.5.1 Dipeptidyl Peptidase-4 Inhibitors Market: Region Footprint
3.5.2 Dipeptidyl Peptidase-4 Inhibitors Market: Company Product Type Footprint
3.5.3 Dipeptidyl Peptidase-4 Inhibitors Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Dipeptidyl Peptidase-4 Inhibitors Market Size by Region
4.1.1 Global Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Region (2018-2029)
4.1.2 Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Region (2018-2029)
4.1.3 Global Dipeptidyl Peptidase-4 Inhibitors Average Price by Region (2018-2029)
4.2 North America Dipeptidyl Peptidase-4 Inhibitors Consumption Value (2018-2029)
4.3 Europe Dipeptidyl Peptidase-4 Inhibitors Consumption Value (2018-2029)
4.4 Asia-Pacific Dipeptidyl Peptidase-4 Inhibitors Consumption Value (2018-2029)
4.5 South America Dipeptidyl Peptidase-4 Inhibitors Consumption Value (2018-2029)
4.6 Middle East and Africa Dipeptidyl Peptidase-4 Inhibitors Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Type (2018-2029)
5.2 Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Type (2018-2029)
5.3 Global Dipeptidyl Peptidase-4 Inhibitors Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Application (2018-2029)
6.2 Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Application (2018-2029)
6.3 Global Dipeptidyl Peptidase-4 Inhibitors Average Price by Application (2018-2029)
7 North America
7.1 North America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Type (2018-2029)
7.2 North America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Application (2018-2029)
7.3 North America Dipeptidyl Peptidase-4 Inhibitors Market Size by Country
7.3.1 North America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Country (2018-2029)
7.3.2 North America Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Type (2018-2029)
8.2 Europe Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Application (2018-2029)
8.3 Europe Dipeptidyl Peptidase-4 Inhibitors Market Size by Country
8.3.1 Europe Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Country (2018-2029)
8.3.2 Europe Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Dipeptidyl Peptidase-4 Inhibitors Market Size by Region
9.3.1 Asia-Pacific Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Type (2018-2029)
10.2 South America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Application (2018-2029)
10.3 South America Dipeptidyl Peptidase-4 Inhibitors Market Size by Country
10.3.1 South America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Country (2018-2029)
10.3.2 South America Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Market Size by Country
11.3.1 Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Dipeptidyl Peptidase-4 Inhibitors Market Drivers
12.2 Dipeptidyl Peptidase-4 Inhibitors Market Restraints
12.3 Dipeptidyl Peptidase-4 Inhibitors Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Dipeptidyl Peptidase-4 Inhibitors and Key Manufacturers
13.2 Manufacturing Costs Percentage of Dipeptidyl Peptidase-4 Inhibitors
13.3 Dipeptidyl Peptidase-4 Inhibitors Production Process
13.4 Dipeptidyl Peptidase-4 Inhibitors Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Dipeptidyl Peptidase-4 Inhibitors Typical Distributors
14.3 Dipeptidyl Peptidase-4 Inhibitors Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Dipeptidyl Peptidase-4 Inhibitors Product and Services
Table 6. Merck Dipeptidyl Peptidase-4 Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer Ingelheim Major Business
Table 10. Boehringer Ingelheim Dipeptidyl Peptidase-4 Inhibitors Product and Services
Table 11. Boehringer Ingelheim Dipeptidyl Peptidase-4 Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Boehringer Ingelheim Recent Developments/Updates
Table 13. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 14. AstraZeneca Major Business
Table 15. AstraZeneca Dipeptidyl Peptidase-4 Inhibitors Product and Services
Table 16. AstraZeneca Dipeptidyl Peptidase-4 Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. AstraZeneca Recent Developments/Updates
Table 18. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Takeda Pharmaceutical Major Business
Table 20. Takeda Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product and Services
Table 21. Takeda Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Takeda Pharmaceutical Recent Developments/Updates
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Dipeptidyl Peptidase-4 Inhibitors Product and Services
Table 26. Novartis Dipeptidyl Peptidase-4 Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Novartis Recent Developments/Updates
Table 28. Jiangsu Hansoh Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Jiangsu Hansoh Pharmaceutical Major Business
Table 30. Jiangsu Hansoh Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product and Services
Table 31. Jiangsu Hansoh Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
Table 33. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Qilu Pharmaceutical Major Business
Table 35. Qilu Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product and Services
Table 36. Qilu Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Qilu Pharmaceutical Recent Developments/Updates
Table 38. Beijing Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Beijing Tide Pharmaceutical Major Business
Table 40. Beijing Tide Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product and Services
Table 41. Beijing Tide Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Beijing Tide Pharmaceutical Recent Developments/Updates
Table 43. CTTQ Basic Information, Manufacturing Base and Competitors
Table 44. CTTQ Major Business
Table 45. CTTQ Dipeptidyl Peptidase-4 Inhibitors Product and Services
Table 46. CTTQ Dipeptidyl Peptidase-4 Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. CTTQ Recent Developments/Updates
Table 48. Jiangsu Deyuan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. Jiangsu Deyuan Pharmaceutical Major Business
Table 50. Jiangsu Deyuan Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product and Services
Table 51. Jiangsu Deyuan Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
Table 53. Jiujiang Zhongtian Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Jiujiang Zhongtian Pharmaceutical Major Business
Table 55. Jiujiang Zhongtian Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product and Services
Table 56. Jiujiang Zhongtian Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Jiujiang Zhongtian Pharmaceutical Recent Developments/Updates
Table 58. Yabao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Yabao Pharmaceutical Major Business
Table 60. Yabao Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product and Services
Table 61. Yabao Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Yabao Pharmaceutical Recent Developments/Updates
Table 63. Global Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Dipeptidyl Peptidase-4 Inhibitors Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Dipeptidyl Peptidase-4 Inhibitors, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Dipeptidyl Peptidase-4 Inhibitors Production Site of Key Manufacturer
Table 68. Dipeptidyl Peptidase-4 Inhibitors Market: Company Product Type Footprint
Table 69. Dipeptidyl Peptidase-4 Inhibitors Market: Company Product Application Footprint
Table 70. Dipeptidyl Peptidase-4 Inhibitors New Market Entrants and Barriers to Market Entry
Table 71. Dipeptidyl Peptidase-4 Inhibitors Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Dipeptidyl Peptidase-4 Inhibitors Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Dipeptidyl Peptidase-4 Inhibitors Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Dipeptidyl Peptidase-4 Inhibitors Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Dipeptidyl Peptidase-4 Inhibitors Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Dipeptidyl Peptidase-4 Inhibitors Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Dipeptidyl Peptidase-4 Inhibitors Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Dipeptidyl Peptidase-4 Inhibitors Raw Material
Table 131. Key Manufacturers of Dipeptidyl Peptidase-4 Inhibitors Raw Materials
Table 132. Dipeptidyl Peptidase-4 Inhibitors Typical Distributors
Table 133. Dipeptidyl Peptidase-4 Inhibitors Typical Customers
List of Figures
Figure 1. Dipeptidyl Peptidase-4 Inhibitors Picture
Figure 2. Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value Market Share by Type in 2022
Figure 4. Sitagliptin Examples
Figure 5. Saxagliptin Examples
Figure 6. Vildagliptin Examples
Figure 7. Linagliptin Examples
Figure 8. Alogliptin Examples
Figure 9. Other Examples
Figure 10. Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 11. Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value Market Share by Application in 2022
Figure 12. Hospital Examples
Figure 13. Clinic Examples
Figure 14. Other Examples
Figure 15. Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Dipeptidyl Peptidase-4 Inhibitors Sales Quantity (2018-2029) & (K Units)
Figure 18. Global Dipeptidyl Peptidase-4 Inhibitors Average Price (2018-2029) & (US$/Unit)
Figure 19. Global Dipeptidyl Peptidase-4 Inhibitors Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Dipeptidyl Peptidase-4 Inhibitors by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Dipeptidyl Peptidase-4 Inhibitors Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Dipeptidyl Peptidase-4 Inhibitors Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Dipeptidyl Peptidase-4 Inhibitors Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Dipeptidyl Peptidase-4 Inhibitors Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Dipeptidyl Peptidase-4 Inhibitors Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Dipeptidyl Peptidase-4 Inhibitors Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Dipeptidyl Peptidase-4 Inhibitors Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Dipeptidyl Peptidase-4 Inhibitors Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Dipeptidyl Peptidase-4 Inhibitors Average Price by Type (2018-2029) & (US$/Unit)
Figure 34. Global Dipeptidyl Peptidase-4 Inhibitors Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Dipeptidyl Peptidase-4 Inhibitors Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Dipeptidyl Peptidase-4 Inhibitors Average Price by Application (2018-2029) & (US$/Unit)
Figure 37. North America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Dipeptidyl Peptidase-4 Inhibitors Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Dipeptidyl Peptidase-4 Inhibitors Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Dipeptidyl Peptidase-4 Inhibitors Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Dipeptidyl Peptidase-4 Inhibitors Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Dipeptidyl Peptidase-4 Inhibitors Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Dipeptidyl Peptidase-4 Inhibitors Consumption Value Market Share by Region (2018-2029)
Figure 57. China Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Dipeptidyl Peptidase-4 Inhibitors Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Dipeptidyl Peptidase-4 Inhibitors Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Dipeptidyl Peptidase-4 Inhibitors Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Dipeptidyl Peptidase-4 Inhibitors Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Dipeptidyl Peptidase-4 Inhibitors Market Drivers
Figure 78. Dipeptidyl Peptidase-4 Inhibitors Market Restraints
Figure 79. Dipeptidyl Peptidase-4 Inhibitors Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Dipeptidyl Peptidase-4 Inhibitors in 2022
Figure 82. Manufacturing Process Analysis of Dipeptidyl Peptidase-4 Inhibitors
Figure 83. Dipeptidyl Peptidase-4 Inhibitors Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source